Arcuro Medical

What Arcuro Medical does

Arcuro Medical is a privately held medical device company founded in 2014 and headquartered in Misgav, Israel, with U.S. operations anchored in Bethlehem, Pennsylvania. The company develops the SuperBall® All-Suture Soft Tissue Repair System, a proprietary platform that delivers knotless fixation with controlled tensioning via a proprietary mesh construct. Its commercial product lines are the SuperBall-MR Meniscus Repair System and, following U.S. FDA clearance in early 2025, the SuperBall-RC Rotator Cuff Repair System. The technology is protected by patents granted in the United States, China, and Europe, and is supported by ISO 13845 quality certification, FDA 510(k) clearance, and CE Mark certification.

Arcuro targets orthopedic surgeons and sports medicine specialists performing soft-tissue repair in the knee and shoulder, as well as the hospitals and ambulatory surgical centers where these procedures take place. The company's revenue model is hardware sales of its repair systems, supplemented by clinical training and surgeon support services. It commercializes through a U.S. direct sales footprint with field representatives, paired with distribution logistics for international (outside-U.S.) markets. Pricing is quote-based and not publicly disclosed. The company has accumulated thousands of patient cases since 2020 and reported a 98.6% deployment success rate with no device-related complications in a 140-patient multi-center post-market evaluation.

In January 2025, Arcuro closed a Series A funding round led by Varana Capital with participation from Trendlines and Consensus Business Group, with proceeds earmarked for operations expansion and continued development of the SuperBall Meniscal Repair System. The company is led by CEO and founder Lee Ranon and operates with a workforce of 11–50 employees. Its addressable market spans the global meniscus repair market projected to grow from $458.6 million in 2021 to $1.04 billion by 2031 at an 8.6% CAGR, plus a $389 million rotator cuff indication, for a combined ~$1.1 billion opportunity by 2028.

Name

Arcuro Medical

Legal name

Arcuro Medical, Inc.

Website

https://arcuromedical.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Arcuro Medical develops the SuperBall® All-Suture Soft Tissue Repair System, a platform for meniscus and rotator cuff repair. The Israel-based company serves orthopedic surgeons and hospitals across the US, Europe, and Israel with FDA-cleared and CE-marked knotless fixation devices.

Ownership category

akta.pro rank

Product category

Orthopedic Soft-Tissue Repair Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF)

Keywords

• Meniscus repair systems
• Rotator cuff repair devices
• Soft tissue repair
• All-suture orthopedic implants
• Sports medicine devices

Headquarters

HQ city

Misgav

HQ country

Israel

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of SuperBall repair systems (SuperBall-MR Meniscus Repair System and SuperBall-RC Rotator Cuff Repair System) to healthcare providers and hospitals
2. Clinical Training and Support: Training services and clinical support for surgeons using the SuperBall platform, supporting product adoption and best practices

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Arcuro Medical develops and commercializes the SuperBall® All-Suture Soft Tissue Repair System, an all-suture platform technology providing knotless fixation with controlled tensioning and a proprietary mesh construct. The platform includes the SuperBall-MR Meniscus Repair System for meniscal tear repair and the SuperBall-RC Rotator Cuff Repair System for soft-tissue repair and augmentation, both targeting orthopedic surgeons and sports medicine specialists performing joint preservation procedures.

Product overview

Arcuro Medical offers a unified platform architecture built around the SuperBall® All-Suture Soft Tissue Repair System. The platform includes two specialized product lines: the SuperBall-MR for meniscus repair and the SuperBall-RC for rotator cuff repair. Both products share the core all-suture technology with controlled tensioning and knotless fixation capabilities, enabling the platform to address multiple soft-tissue repair applications while maintaining consistent surgical technique across procedures.

Differentiator

Problem solved

Functional benefit

Brands

• SuperBall: All-suture soft-tissue repair platform for meniscus and rotator cuff procedures with controlled tensioning and knotless fixation.

Products and services

• SuperBall® All-Suture Soft Tissue Repair System Flagship all-suture soft-tissue repair platform providing strong, knotless fixation with controlled tensioning and a proprietary mesh construct for meniscal and rotator cuff procedures; targeted at orthopedic surgeons and sports medicine specialists.
• SuperBall-MR Meniscus Repair System All-suture meniscus repair system designed for meniscal tear repairs, part of the SuperBall platform with controlled tensioning and dependable fixation for orthopedic and sports medicine procedures.
• SuperBall-RC Rotator Cuff Repair System All-suture rotator cuff repair system for soft-tissue repair and augmentation procedures, cleared by U.S. FDA in early 2025 and targeted at orthopedic surgeons and sports medicine specialists.

Quantifiable outcome

• 98.6% deployment success rate with no device-related complications in 140-patient multi-center post-market evaluation

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Arthrex: Arthrex is the dominant independent sports medicine and orthopedic soft-tissue repair company, offering a broad portfolio of meniscus repair systems, suture anchors, and rotator cuff products — directly competitive with Arcuro's SuperBall platform on the same surgeon customer base.
• Smith & Nephew: Smith & Nephew's sports medicine division offers meniscal repair systems (e.g., FAST-FIX) and rotator cuff anchor products, directly competing with SuperBall-MR and SuperBall-RC in the same hospitals and orthopedic surgery channels.
• Johnson & Johnson (DePuy Synthes Mitek Sports Medicine): DePuy Synthes Mitek Sports Medicine offers meniscus repair (TRUESPAN) and rotator cuff anchor systems (HEALICOIL) targeted at the same orthopedic sports medicine surgeons, making J&J a direct peer in the soft-tissue repair space.
• Stryker: Stryker's sports medicine business includes arthroscopic soft-tissue repair products for meniscus and rotator cuff procedures, competing head-to-head with Arcuro in U.S. ambulatory surgical centers and hospital systems.
• Conmed: Conmed manufactures sports medicine products including meniscal repair and shoulder/rotator cuff systems, overlapping directly with the SuperBall platform's indications and target surgeon customers.
• Zimmer Biomet: Zimmer Biomet's sports medicine, surgical, and orthobiologics portfolio includes meniscus and shoulder soft-tissue repair devices that compete with Arcuro's SuperBall-MR and SuperBall-RC in hospitals and ambulatory surgery centers.

Emerging players

• Anika Therapeutics: Anika Therapeutics develops orthobiologics and hyaluronic-acid based treatments for joint preservation including meniscus-related indications, making it an emerging peer that targets the same joint-preservation clinical use cases as Arcuro, though via a regenerative rather than suture-based approach.

Broad incumbents

• Integra LifeSciences: Integra LifeSciences is a broader surgical and orthopedic device incumbent with sports medicine and tissue repair offerings; its wider portfolio overlaps with Arcuro's hospital and surgical center channels but it does not focus exclusively on soft-tissue repair.
• Olympus (Orthopedic Business): Olympus has an arthroscopy and orthopedic surgical device presence that competes in the same operating-room channels as Arcuro, though as part of a much larger endoscopy and medical device portfolio rather than a focused sports medicine franchise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arcuro Medical